Found 0 matching trials
RT for Adenocarcinoma/Adenosquamous Carcinoma PHASE1 This study aims to establish a prospective cohort of locally advanced cervi...
Show More Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Learn More & Join Trial
PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma N/A The prognostic value of programmed death-ligand 1 (PD-L1) and BRAF expressi...
Show More Location
Kiang Wu Hospital
Learn More & Join Trial
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors PHASE1 This phase I/II clinical trial evaluates the safety, efficacy, and prognost...
Show More Status
Enrolling By Invitation
Location
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Learn More & Join Trial
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer PHASE2 This study was conducted to evaluate the preliminary effectiveness and safe...
Show More Location
The First Affiliated Hospital of Wannan Medical College
Learn More & Join Trial
Effect of Chemotherapy on PD-L1 in NSCLC N/A PD-L1 is identified as an important biomarkers for predicting PD-1/PD-L1 in...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration N/A In this study, investigators utilize a radiopathomics integrated Artificial...
Show More Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy NA A pilot study with biomarker exploration.50 patients with stage IV non-smal...
Show More Location
VU medical center
Learn More & Join Trial
Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers PHASE1 Background:
The drug Interleukin-15 (IL-15) activates the immune system. T...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice N/A This is a non-interventional, multi-country, multi-centre, multicohort, pri...
Show More Location
Landesklinikum Krems
Learn More & Join Trial
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer PHASE2 This is an open-label, multi-center, Phase 2 study in subjects with treatme...
Show More Location
The Second Hospital of Anhui Medical University
Learn More & Join Trial